Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
作者信息
Jones R, Franklin K, Spicer R, Berry J
出版信息
Lancet. 1995 Aug 19;346(8973):499.
PMID:7543641
Abstract
摘要
相似文献
1
Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.接受低剂量胰酶治疗的囊性纤维化患儿的结肠狭窄
Lancet. 1995 Aug 19;346(8973):499.
2
Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.患有囊性纤维化且服用低剂量胰酶的儿童的结肠狭窄
Lancet. 1995 Aug 19;346(8973):499-500.
3
High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.高强度胰酶补充剂与囊性纤维化患者的大肠狭窄
Lancet. 1994 Jan 8;343(8889):109.
4
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation.接受高剂量酶补充治疗的囊性纤维化患儿的肠道炎症
Lancet. 1996 Feb 3;347(8997):327. doi: 10.1016/s0140-6736(96)90501-2.
5
6
Managing childhood gastro-oesophageal reflux.
Drug Ther Bull. 1997 Oct;35(10):77-80. doi: 10.1136/dtb.1997.351077.
7
Gaviscon for gastro-oesophageal reflux in infants: a poorly effective treatment?加胃斯康用于治疗婴儿胃食管反流：一种疗效不佳的治疗方法？
Arch Dis Child. 2006 Jan;91(1):93. doi: 10.1136/adc.2005.086355.
8
Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.囊性纤维化和高强度胰酶患者的升结肠狭窄
Lancet. 1994 Jan 8;343(8889):85-6. doi: 10.1016/s0140-6736(94)90817-6.
9
Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements.
Lancet. 1995 Nov 11;346(8985):1265-7. doi: 10.1016/s0140-6736(95)91864-7.
10
The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.藻酸钠（吉福森）治疗早产儿胃食管反流的疗效。
Aliment Pharmacol Ther. 2011 Feb;33(4):466-70. doi: 10.1111/j.1365-2036.2010.04545.x. Epub 2010 Dec 15.
引用本文的文献
1
Chitosan nanoencapsulated exogenous trypsin biomimics zymogen-like enzyme in fish gastrointestinal tract.壳聚糖纳米包封的外源性胰蛋白酶仿生物在鱼类胃肠道中呈现酶原样酶。
PLoS One. 2013 Sep 10;8(9):e74743. doi: 10.1371/journal.pone.0074743. eCollection 2013.
2
Control of malabsorption in cystic fibrosis.囊性纤维化中吸收不良的控制
Paediatr Drugs. 2000 May-Jun;2(3):205-22. doi: 10.2165/00128072-200002030-00005.
3
Update on intestinal strictures.肠道狭窄的最新情况。
J R Soc Med. 1999;92 Suppl 37(Suppl 37):41-9. doi: 10.1177/014107689909237S08.
4
Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.囊性纤维化患者的结肠壁厚度、胰酶剂量及制剂类型
Arch Dis Child. 1998 Oct;79(4):339-43. doi: 10.1136/adc.79.4.339.
5
Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.超声测量的结肠壁厚度：囊性纤维化患者与健康对照者之间存在显著差异。
Gut. 1997 Mar;40(3):406-11. doi: 10.1136/gut.40.3.406.
6
Bezoars: implicated drugs and avoidance strategies.胃石：相关药物及预防策略
Drug Saf. 1996 Feb;14(2):85-93. doi: 10.2165/00002018-199614020-00003.
7
Subclinical colonic thickening.亚临床结肠增厚
J R Soc Med. 1996;89 Suppl 27(Suppl 27):24-30.
8
Fibrosing colonopathy: recent advances.纤维性结肠病：最新进展
J R Soc Med. 1996;89 Suppl 27(Suppl 27):19-23.
9
Adverse drug events related to dosage forms and delivery systems.与剂型和给药系统相关的药物不良事件。
Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005.
10
Fibrosing colonopathy in cystic fibrosis.囊性纤维化中的纤维性结肠病
Arch Dis Child. 1996 May;74(5):464-8. doi: 10.1136/adc.74.5.464.
Zotero 插件